New drug aims to calm lungs in severe pneumonia
Disease control
Recruiting now
This study is testing a new drug called AV-001 for adults hospitalized with pneumonia from COVID-19 or other infections. The goal is to see if the drug is safe and if it can help patients improve by reducing lung inflammation and damage, potentially helping them breathe better an…
Phase: PHASE2 • Sponsor: Vasomune Therapeutics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC